Yeoman Care Limited 03053472 false 2024-04-01 2025-03-31 2025-03-31 The principal activity of the company is the provision of accommodation and nursing care for the elderly. Digita Accounts Production Advanced 6.30.9574.0 true true 03053472 2024-04-01 2025-03-31 03053472 2025-03-31 03053472 bus:OrdinaryShareClass1 2025-03-31 03053472 core:CapitalRedemptionReserve 2025-03-31 03053472 core:RetainedEarningsAccumulatedLosses 2025-03-31 03053472 core:ShareCapital 2025-03-31 03053472 core:CurrentFinancialInstruments 2025-03-31 03053472 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 03053472 core:FurnitureFittingsToolsEquipment 2025-03-31 03053472 bus:SmallEntities 2024-04-01 2025-03-31 03053472 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 03053472 bus:FilletedAccounts 2024-04-01 2025-03-31 03053472 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 03053472 bus:RegisteredOffice 2024-04-01 2025-03-31 03053472 bus:Director1 2024-04-01 2025-03-31 03053472 bus:Director4 2024-04-01 2025-03-31 03053472 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 03053472 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 03053472 core:Goodwill 2024-04-01 2025-03-31 03053472 core:FurnitureFittingsToolsEquipment 2024-04-01 2025-03-31 03053472 core:Land 2024-04-01 2025-03-31 03053472 core:LandBuildings 2024-04-01 2025-03-31 03053472 1 2024-04-01 2025-03-31 03053472 1 2024-04-01 2025-03-31 03053472 countries:AllCountries 2024-04-01 2025-03-31 03053472 2024-03-31 03053472 core:FurnitureFittingsToolsEquipment 2024-03-31 03053472 2022-12-01 2024-03-31 03053472 2024-03-31 03053472 bus:OrdinaryShareClass1 2024-03-31 03053472 core:CapitalRedemptionReserve 2024-03-31 03053472 core:RetainedEarningsAccumulatedLosses 2024-03-31 03053472 core:ShareCapital 2024-03-31 03053472 core:CurrentFinancialInstruments 2024-03-31 03053472 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 03053472 core:FurnitureFittingsToolsEquipment 2024-03-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 03053472

Yeoman Care Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 March 2025

 

Yeoman Care Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 9

 

Yeoman Care Limited

Company Information

Directors

Mrs Cheryl Lynn Lawrence

Mr Luke Venn

Registered office

19 Albert Road
Weston-Super-Mare
BS23 1ES

 

Yeoman Care Limited

(Registration number: 03053472)
Abridged Balance Sheet as at 31 March 2025

Note

2025
£

2024
£

Fixed assets

 

Tangible assets

5

8,558

12,450

Current assets

 

Stocks

6

6,000

-

Debtors

75,892

516,062

Cash at bank and in hand

 

150,240

140,851

 

232,132

656,913

Creditors: Amounts falling due within one year

(170,896)

(188,095)

Net current assets

 

61,236

468,818

Net assets

 

69,794

481,268

Capital and reserves

 

Called up share capital

7

1,000

1,000

Capital redemption reserve

57,500

57,500

Retained earnings

11,294

422,768

Shareholders' funds

 

69,794

481,268

For the financial year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 26 November 2025 and signed on its behalf by:
 

 

Yeoman Care Limited

(Registration number: 03053472)
Abridged Balance Sheet as at 31 March 2025

.........................................
Mrs Cheryl Lynn Lawrence
Director

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

1

General information

The company is a private company limited by share capital, incorporated in England & Wales.

The address of its registered office is:
19 Albert Road
Weston-Super-Mare
BS23 1ES

These financial statements were authorised for issue by the Board on 26 November 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

Disclosure of long or short period

The financial statements cover the year from 1 April 2024 to 31 March 2025, whilst the comparative figures cover the 18 month period ended 31 March 2024. The company’s accounting reference date was changed in the prior period in order to bring the company’s reporting period in line with that of the group to which it belongs. The figures reported for the year ended 31 March 2025 are therefore not directly comparable to the figures reported for the 18 month period ended 31 March 2024.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Tax

The tax expense for the period comprises tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Freehold land

0%

Freehold buildings

4% straight line

Fixtutes, fittings and equipment

20% straight line

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 54 (2024 - 53).

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

4

Intangible assets

Total
£

Cost or valuation

At 1 April 2024

80,000

At 31 March 2025

80,000

Amortisation

At 1 April 2024

80,000

At 31 March 2025

80,000

Carrying amount

At 31 March 2025

-

5

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 April 2024

492,291

492,291

Additions

820

820

At 31 March 2025

493,111

493,111

Depreciation

At 1 April 2024

479,841

479,841

Charge for the year

4,712

4,712

At 31 March 2025

484,553

484,553

Carrying amount

At 31 March 2025

8,558

8,558

At 31 March 2024

12,450

12,450

6

Stocks

2025
£

2024
£

Other inventories

6,000

-

 

Yeoman Care Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 March 2025

7

Share capital

Allotted, called up and fully paid shares

2025

2024

No.

£

No.

£

Ordinary of £1 each

1,000

1,000

1,000

1,000

       

8

Financial commitments, guarantees and contingencies

Amounts not provided for in the balance sheet

The total amount of financial commitments not included in the balance sheet is £23,052 (2024 - £33,201).

9

Parent and ultimate parent undertaking

Yeoman Care Limited is a 100% subsidiary of Amandi Curae Limited. The registered office of Amandi Curae Limited, which is also its principal place of business, is 20 Manor Farm Crescent, Bradley Stoke, Bristol, BS32 9BD.


 The company's immediate parent is Amandi Curae Limited, incorporated in England & Wales.